Clinical Trial Update: Trial to Evaluate 2 Hours of Daily Patching for Amblyopia in Children [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating two hours of daily patching for amblyopia in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amblyopia

Snippet

Sponsor: Jaeb Center for Health Research | Conditions: Amblyopia | Phase 3 | Status: COMPLETED